Express Pharma

Lupin appoints Fabrice Egros as President of its Asia-Pacific Business


Egros has over 25 years of experience within the global pharmaceutical industry

Fabrice Egros

Lupin has appointed Fabrice Egros as the President, Asia Pacific and Japan. He will be based in Tokyo, Japan. Egros has over 25 years of experience within the global pharmaceutical industry, having worked in leadership roles encompassing P&L management for new markets, mergers and acquisitions, marketing and commercial, global strategy and business development as well as global clinical development, regulatory and manufacturing.

Egros will be responsible for Lupin’s growth and development across key markets such as Japan, Australia, the Philippines, South East Asia and new markets in the rest of the ASEAN region. Prior to joining Lupin, Fabrice was with NovaMedica where he was the Deputy CEO/ COO and instrumental in setting up an integrated new pharma business. Before NovaMedica, he has worked with global majors such as UCB, Sanofi and Parke Davis in various global and regional capacities.

Egros holds a Degree in Pharmacy, a MS in clinical pharmacology and a Doctorate in Pharmaceutical Sciences from the University of Paris (School of Medicine and Pharmacy) as well as a MBA from Schiller University. He has also completed Advanced Management Program from Harvard University.

Nilesh Gupta, Managing Director, Lupin said, “We are delighted to have Egros join the Lupin family. His deep knowledge of the Asia-Pacific markets will be invaluable as we consolidate and grow our business in the region. This region is the third largest revenue contributor for us globally and I believe that Egros’ experience will help Lupin achieve its growth plans for the Asia Pacific region, and help us scale the business to new heights.”

EP News BureauMumbai

Comments are closed.